J Korean Med Sci.  2006 Feb;21(1):151-154. 10.3346/jkms.2006.21.1.151.

A Fatal Case of Severe Hemolytic Disease of Newborn Associated with Anti-Jk(b)

Affiliations
  • 1Department of Pediatrics, Dongguk University, College of Medicine, Gyeongju, Korea.
  • 2Department of Pediatrics, Yeungnam University, College of Medicine, Daegu, Korea. yhlee@medical.yeungnam.ac.kr

Abstract

The Kidd blood group is clinically significant since the Jk antibodies can cause acute and delayed transfusion reactions as well as hemolytic disease of newborn (HDN). In general, HDN due to anti-Jk(b) incompatibility is rare and it usually displays mild clinical symptoms with a favorable prognosis. Yet, we apparently experienced the second case of HDN due to anti-Jk(b) with severe clinical symptoms and a fatal outcome. A female patient having the AB, Rh(D)-positive boodtype was admitted for jaundice on the fourth day after birth. At the time of admission, the patient was lethargic and exhibited high pitched crying. The laboratory data indicated a hemoglobin value of 11.4 mg/dL, a reticulocyte count of 14.9% and a total bilirubin of 46.1 mg/dL, a direct bilirubin of 1.1 mg/dL and a strong positive result (+++) on the direct Coomb's test. As a result of the identification of irregular antibody from the maternal serum, anti-Jk(b) was detected, which was also found in the eluate made from infant's blood. Despite the aggressive treatment with exchange transfusion and intensive phototherapy, the patient died of intractable seizure and acute renal failure on the fourth day of admission. Therefore, pediatricians should be aware of the clinical courses of hemolytic jaundice due to anti-Jk(b), and they should be ready to treat this disease with active therapeutic interventions.

Keyword

Anemia, Hemolytic, Autoimmune; Erythrobastosis, Fetal; Infant, Newborn; Anti-Jk(b)

MeSH Terms

Bilirubin/blood
Erythroblastosis, Fetal/*blood
Fatal Outcome
Female
Humans
Infant, Newborn
Isoantibodies/blood
Kidd Blood-Group System/*immunology

Reference

1. Moise KJ Jr. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med. 1994. 118:421–428.
2. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol. 1997. 89:272–275.
3. Mentzer WC, Glader BE. Taeusch HW, Ballard RA, editors. Erythrocyte disorders in infancy. Avery's diseases of the newborn. 2004. 8th ed. Philadelphia: W.B Saunders Co;1080–1092.
Article
4. Allen FM, Diamond LK, Niedziela B. A new blood group antigen. Nature. 1951. 167:482.
5. Plaut G, Ikin EW, Mourant AE, Sanger R, Race RR. A new bloodgroup antibody, anti Jkb. Nature. 1953. 171:431.
6. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: a continuing problem. Clin Obstet Gynecol. 1982. 25:321–332.
Article
7. Issitt PD, Anstee DJ. Issitt P, editor. The Kidd blood group system. Applied Blood Group Serology. 1998. 4th ed. Durham, NC: Montgomery Scientific Publications;655–670.
8. Olives B, Mattei MG, Huet M, Neau P, Martial S, Cartron JP, Bailly P. Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem. 1995. 270:15607–15610.
9. Sanger R, Race RR, Rosenfield RE, Vogel P. A serum containing anti-s and anti-Jkb. Vox Sang. 1953. 3:115.
10. Rosenfield RE, Ley AB, Haber G, Harris JP. A further example of anti-Jkb. Am J Clin Pathol. 1954. 24:1282–1284.
11. Kornstad L, Halvorsen K. Haemolytic disease of the newborn caused by anti-Jkb. Vox Sang. 1958. 3:94–99.
12. Kelton JG, Heddle NM, Blajchman MA. Blood transfusion. A conceptual approach. 1984. 1st ed. New York: Churchill Livingstone;56.
13. Okubo Y, Yamaguchi H, Nagao N, Tomita T, Seno T, Tanaka M. Heterogeneity of the phenotype Jk(a-b-) found in Japanese. Transfusion. 1986. 26:237–239.
Article
14. Hessner MJ, Pircon RA, Johnson ST, Luhm RA. Prenatal genotyping of Jk(a) and Jk(b) of the human Kidd blood group system by allele-specific polymerase chain reaction. Prenat Diagn. 1998. 18:1225–1231.
Article
15. Geczy A, Eslie M. Second example of hemolytic disease of the newborn caused by anti-Jk-b. Transfusion. 1961. 1:125–127.
Article
16. Wagman E, Bove JR. Anti-Jkb. Hemolytic disease of the newborn caused by anti-Jkb. Am J Clin Pathol. 1964. 41:481–483.
17. Zodin V, Anderson RE. Hemolytic disease of the newborn due to anti-Kidd (Jkb): case report and review of the literature. Pediatrics. 1965. 36:420–422.
18. Lange MM, Lumare A, Corsi C. Hemolytic disease of the newborn caused by anti-Jk-b antibody. Minerva Pediatr. 1974. 26:1765–1767.
19. Kim HO, Kwon OH, Lee SY, Lee YS, Kim SK. A case of hemolytic disease of the newborn due to anti-Jkb. Korean J Hematol. 1986. 21:319–322.
20. Merlob P, Litwin A, Reisner SH, Cohen IJ, Zaizov R. Hemolytic disease of the newborn caused by anti-Jkb. Pediatr Hematol Oncol. 1987. 4:357–360.
21. Tomar V, Dhingra N, Madan N, Faridi MM. Hemolytic disease of the newborn due to maternal anti-Kidd (anti-Jkb). Indian Pediatr. 1998. 35:1251–1253.
22. Park DK, Kim YM, Bae CW, Choi YM, Lee WI. A case of hemolytic disease in a newborn due to Anti-Jkb. Korean J Pediatr. 2003. 46:718–721.
23. Kanner J. Anti-Jkb in erythroblastosis fetalis. Am J Obstet Gynecol. 1962. 83:1253.
24. Nathan DG, Orkin SH, Oski FA. Hematology of Infancy and Childhood. 1998. 5th ed. Philadelphia: W.B Saunders;61–62.
25. Millard DD, Gidding SS, Socol ML, MacGregor SN, Dooley SL, Ney JA, Stockman JA 3rd. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr. 1990. 117:447–454.
Article
26. Moya FR, Grannum PA, Widness JA, Clemons GK, Copel JA, Hobbins JC. Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis. Obstet Gynecol. 1993. 82:353–358.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr